Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes
- PMID: 27544210
- PMCID: PMC11108460
- DOI: 10.1007/s00018-016-2329-4
Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes
Abstract
The skin forms a vital barrier between an organism's external environment, providing protection from pathogens and numerous physical and chemical threats. Moreover, the intact barrier is essential to prevent water and electrolyte loss without which terrestrial life could not be maintained. Accordingly, acute disruption of the skin through physical or chemical trauma needs to be repaired timely and efficiently as sustained skin pathologies ranging from mild irritations and inflammation through to malignancy impact considerably on morbidity and mortality. The Nuclear Hormone Receptor Family of transcriptional regulators has proven to be highly valuable targets for addressing a range of pathologies, including metabolic syndrome and cancer. Indeed members of the classic endocrine sub-group, such as the glucocorticoid, retinoid, and Vitamin D receptors, represent mainstay treatment strategies for numerous inflammatory skin disorders, though side effects from prolonged use are common. Emerging evidence has now highlighted important functional roles for nuclear receptors belonging to the adopted and orphan subgroups in skin physiology and patho-physiology. This review will focus on these subgroups and explore the current evidence that suggests these nuclear receptor hold great promise as future stand-alone or complementary drug targets in treating common skin diseases and maintaining skin homeostasis.
Keywords: LXR; NR4A; Nuclear receptor; Orphan receptors; PPAR; Wound healing.
Figures

Similar articles
-
[Beyond glucocorticoids, retinoids and vitamin D--the evolution of nuclear hormone type transcription factor targeting in the skin].J Dtsch Dermatol Ges. 2003 May;1(5):352-62. doi: 10.1046/j.1610-0387.2003.03001.x. J Dtsch Dermatol Ges. 2003. PMID: 16285300 Review. German.
-
The role of lipid-activated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology.J Allergy Clin Immunol. 2013 Aug;132(2):264-86. doi: 10.1016/j.jaci.2013.05.044. J Allergy Clin Immunol. 2013. PMID: 23905916 Review.
-
Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.Adv Drug Deliv Rev. 2010 Oct 30;62(13):1316-21. doi: 10.1016/j.addr.2010.07.006. Epub 2010 Jul 24. Adv Drug Deliv Rev. 2010. PMID: 20659512 Review.
-
Peroxisome proliferator-activated receptors as new molecular targets in psoriasis.Curr Drug Targets Inflamm Allergy. 2004 Jun;3(2):205-11. doi: 10.2174/1568010043343976. Curr Drug Targets Inflamm Allergy. 2004. PMID: 15180475 Review.
-
Nuclear hormone receptors in human skin.Horm Metab Res. 2007 Feb;39(2):96-105. doi: 10.1055/s-2007-961808. Horm Metab Res. 2007. PMID: 17326005 Review.
Cited by
-
Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression.Cell Discov. 2018 Apr 3;4:15. doi: 10.1038/s41421-018-0014-5. eCollection 2018. Cell Discov. 2018. PMID: 29619245 Free PMC article.
-
Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.Oncogene. 2018 Jan 11;37(2):160-173. doi: 10.1038/onc.2017.319. Epub 2017 Sep 11. Oncogene. 2018. PMID: 28892046 Free PMC article.
-
Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring.Int J Mol Sci. 2020 Feb 7;21(3):1105. doi: 10.3390/ijms21031105. Int J Mol Sci. 2020. PMID: 32046094 Free PMC article. Review.
-
Emerging pharmaceutical therapeutics and delivery technologies for osteoarthritis therapy.Front Pharmacol. 2022 Nov 17;13:945876. doi: 10.3389/fphar.2022.945876. eCollection 2022. Front Pharmacol. 2022. PMID: 36467045 Free PMC article. Review.
-
Current trends in polymer microneedle for transdermal drug delivery.Int J Pharm. 2020 Sep 25;587:119673. doi: 10.1016/j.ijpharm.2020.119673. Epub 2020 Jul 30. Int J Pharm. 2020. PMID: 32739388 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical